Clinical Trial Update: Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

View source ↗

Summary

A completed clinical trial evaluated granulocyte-colony stimulating factor (G-CSF) for prevention of chemotherapy-induced febrile neutropenia across multiple ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Bladder Cancer
• Breast Cancer
• Lung Cancer
• Multiple Myeloma
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Sandoz | Conditions: Febrile Neutropenia, Cancer | Status: COMPLETED | Results posted: 2015-07-07